Benzinga | Mar 11, 2021 04:02PM EST

Assertio Therapeutics Q4 EPS $(0.20) Down From $(0.14) YoY, Sales $29.80M Beat $27.65M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly losses of $(0.20) per share. This is a 42.86 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $29.80 million which beat the analyst consensus estimate of $27.65 million by 7.78 percent. This is a 49.68 percent decrease over sales of $59.23 million the same period last year.